On December 19, 2025, Cero Therapeutics Holdings, Inc. stockholders approved increasing the equity incentive plan by 32 million shares and proposed a reverse stock split of 1-for-40 to 1-for-150. This event is significant as it impacts the company's capital structure and potential value share.